USPTO serial 88409571

NEXT GEN PLACEBOS

Reg. 6081439Status 700Renewal

Need help with NEXT GEN PLACEBOS?

CopyMark Law Group can help you respond to USPTO correspondence, keep a registration alive, or watch new filings against your mark.

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Deadline: June 16th, 2026

Class	Description	Status	First use
005	Placebo pills for medical use	ACTIVE	Mar 30, 2020

Date	Code	Event
Jun 16, 2025	REM1	COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jun 16, 2020	R.PR	REGISTERED-PRINCIPAL REGISTER
May 12, 2020	SUNA	NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
May 9, 2020	CNPR	ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Apr 16, 2020	SUPC	STATEMENT OF USE PROCESSING COMPLETE
Apr 15, 2020	AITU	CASE ASSIGNED TO INTENT TO USE PARALEGAL
Mar 30, 2020	IUAF	USE AMENDMENT FILED
Mar 30, 2020	EISU	TEAS STATEMENT OF USE RECEIVED
Oct 29, 2019	NOAM	NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 3, 2019	NPUB	OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 3, 2019	PUBO	PUBLISHED FOR OPPOSITION
Aug 14, 2019	NONP	NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 26, 2019	ALIE	ASSIGNED TO LIE
Jul 16, 2019	CNSA	APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 16, 2019	XAEC	EXAMINER'S AMENDMENT ENTERED
Jul 16, 2019	GNEN	NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jul 16, 2019	GNEA	EXAMINERS AMENDMENT E-MAILED
Jul 16, 2019	CNEA	EXAMINERS AMENDMENT -WRITTEN
Jul 11, 2019	DOCK	ASSIGNED TO EXAMINER
May 17, 2019	NWOS	NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 3, 2019	NWAP	NEW APPLICATION ENTERED